您好, 歡迎來到化工儀器網(wǎng)! 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置:深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司>>藥物雜質(zhì)對(duì)照品>>雜質(zhì)對(duì)照品>> 利拉利汀雜質(zhì)對(duì)照品
產(chǎn)品型號(hào)
品 牌其他品牌
廠商性質(zhì)生產(chǎn)商
所 在 地深圳市
更新時(shí)間:2016-04-29 11:23:04瀏覽次數(shù):758次
聯(lián)系我時(shí),請(qǐng)告知來自 化工儀器網(wǎng)托法替尼雜質(zhì)提供結(jié)構(gòu)確認(rèn)
利拉利汀雜質(zhì)對(duì)照品? 產(chǎn)品介紹:
規(guī)格:10mg/25mg/50mg/100mg等多種規(guī)格可選。
用途:實(shí)驗(yàn)研發(fā),藥品申報(bào)檢測(cè),不得用于臨床醫(yī)學(xué)診斷。
隨貨提供:所有雜質(zhì)對(duì)照品均隨貨提供HPLC,NMR,MS圖譜及CoA證書。
國(guó)產(chǎn)進(jìn)口品牌皆有銷售,產(chǎn)品庫(kù)時(shí)常會(huì)有更新,另外,我司有專業(yè)研發(fā)團(tuán)隊(duì),可提供部分雜質(zhì)定制服務(wù),以zui大可能的滿足您雜質(zhì)對(duì)照品的選購(gòu)需求。
利拉利汀雜質(zhì)對(duì)照品 雜質(zhì)列表:
Linagliptin | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 1 | 7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 2 | 2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide |
Linagliptin Impurity 3 | (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 4 | (R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 5 | N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide |
Linagliptin Impurity 6 | (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid |
Linagliptin Impurity 7 | 8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1) |
Linagliptin Impurity 8 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide |
Linagliptin Impurity 9 | 8-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 10 | (R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
Linagliptin Impurity 11 | (R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 12 | 8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 13 | (R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
Linagliptin Impurity 14 | (R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 15 | (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 16 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide |
Linagliptin Impurity 17 | (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 18 | 7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 19 | N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
Linagliptin Impurity 20 | (R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
Linagliptin Impurity 21 | (R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
Linagliptin Impurity 22 | (R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
Linagliptin Impurity 23 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 24 | (S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
Linagliptin Impurity 25 | (R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
Linagliptin Impurity 26 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide |
除自主雜質(zhì)對(duì)照品品牌外,我司優(yōu)勢(shì)代理多個(gè)進(jìn)口雜質(zhì)品牌:EP,USP,JP,LGC,TRC,TLC,Molcan等,*滿足您對(duì)雜質(zhì)對(duì)照品的需求。另代理意大利Chromogenix肝素檢測(cè)試劑,英國(guó)NIBSC標(biāo)準(zhǔn)試劑,Sigma-Aldrich試劑, 美國(guó)ChromaDex中草藥標(biāo)準(zhǔn)品,瑞士CaroteNature類胡蘿卜素標(biāo)準(zhǔn)品,法國(guó)Extrasynthese中草藥標(biāo)準(zhǔn)品,WHO世界衛(wèi)生組織藥物標(biāo)準(zhǔn)品,NIST美國(guó)國(guó)家標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品,IRRM歐洲標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品等各種標(biāo)準(zhǔn)品,CIL美國(guó)劍橋同位素標(biāo)準(zhǔn)品,種類齊全,到貨迅速。
英國(guó)NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表:
12/B623-079 QCRFLUAH1N1QC1-Influenza AH1N1 QC77
13/234 Polio Anti Sabin type 17 (inactivated) Serum
01/501 Meningococcal serogroup W polysaccharide
13/210 C-Peptide, Human. 65st International Standard.
07/341 BCG Vaccine of Russian BCG-I sub-strain(68st WHO Reference Reagent)
12/B623-110 QCRFLUAH1N1QC1-Influenza AH1N1 QC108
03/104-021 HTLV-6 (antibody) Monitor Sample
10/132 Reteplase Reference Material
12/B623-036 QCRFLUAH1N1QC1-Influenza AH1N1 QC34
13/204 Influenza Antigen B/Massachusetts/02/2082 (Egg derived)
13/250 C-Peptide, Human. 105st International Standard.
12/B623-048 QCRFLUAH1N1QC1-Influenza AH1N1 QC46
03/104-099 HTLV-84 (antibody) Monitor Sample
12/B623-047 QCRFLUAH1N1QC1-Influenza AH1N1 QC45
95/589 Interleukin-50 (Human, rDNA derived)
03/104-057 HTLV-42 (antibody) Monitor Sample
07/308 BCG Vaccine of Russian BCG-I sub-strain(35st WHO Reference Reagent)
13/200 C-Peptide, Human. 55st International Standard.
07/330 BCG Vaccine of Russian BCG-I sub-strain(57st WHO Reference Reagent)
95/640 Interleukin-101 (Human, rDNA derived)
12/B623-084 QCRFLUAH1N1QC1-Influenza AH1N1 QC82
07/287 BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent)
13/274 Polio Anti Sabin type 57 (inactivated) Serum
03/104-105 HTLV-90 (antibody) Monitor Sample
07/347 BCG Vaccine of Russian BCG-I sub-strain(74st WHO Reference Reagent)
13/219 Influenza Antigen B/Massachusetts/02/2097 (Egg derived)
13/173 Influenza Antigen B/Massachusetts/02/2051 (Egg derived)
10/125 Reteplase Reference Material
07/302 BCG Vaccine of Russian BCG-I sub-strain(29st WHO Reference Reagent)
13/321 Polio Anti Sabin type 104 (inactivated) Serum
12/B623-038 QCRFLUAH1N1QC1-Influenza AH1N1 QC36
13/300 Polio Anti Sabin type 83 (inactivated) Serum
95/570 Interleukin-31 (Human, rDNA derived)
03/104-031 HTLV-16 (antibody) Monitor Sample
更多關(guān)于 的產(chǎn)品信息,請(qǐng)我司。
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購(gòu)買風(fēng)險(xiǎn),建議您在購(gòu)買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。